BLING III: A phase III randomised controlled trial of continuous beta-lactam infusion compared with intermittent beta-lactam dosing in critically ill patients [ 2017 - ]

Research Grant

Researchers: Prof Jeffrey Lipman (Principal investigator) ,  A/Pr Jan De Waele ,  Dr Joel Dulhunty ,  Dr Shay McGuinness ,  Prof Andrew Rhodes
View all 10 related researchers

Brief description This Australian-led trial of global significance will provide definitive clinical evidence of the optimal method for treating patients with severe sepsis using beta-lactam antibiotics. The trial will compare whether continuous infusion of beta-lactam antibiotics improves outcomes for patients compared with standard intermittent dosing. The potential significance of this trial is that it may lead to a simple and cost-effective intervention to improve survival for patients with severe infections.

Funding Amount $3,269,943.00

Funding Scheme Project Grants

Notes Standard Project Grant